ATDBIO
Desconocido
NATURE-ETN: Nucleic Acids for Future Gene Editing Immunotherapy and Epigenetic Sequence Modification
ATDBIO LIMITED
participó en un
H2020:
H2020-MSCA-ITN-2019
Nucleic acid (NAs) therapies are predicted to yield major advances in the treatment of human disease and new approaches in NA design are req...
2020-02-05 - 2024-09-30 | Financiado
2020-02-05 - 2024-09-30 | Financiado
DNA-Robotics: DNA Based Modular Nanorobotics
ATDBIO LIMITED
participó en un
H2020:
H2020-MSCA-ITN-2017
Robotic systems essentially comprise sensors and actuators connected to and coordinated by an information-processing unit. These principles...
2017-08-29 - 2022-06-30 | Financiado
2017-08-29 - 2022-06-30 | Financiado
ClickGene: Click Chemistry for Future Gene Therapies to Benefit Citizens Researchers and Industry
ATDBIO LIMITED
participó en un
H2020:
H2020-MSCA-ITN-2014
Gene therapy is expected to play a key role in next-generation medicine by correcting the underlying genetic causes of disease, thereby faci...
2014-12-05 - 2018-12-31 | Financiado
2014-12-05 - 2018-12-31 | Financiado
* No se disponen de datos de la empresa actual.